Women fare better than men, but need more blood after kidney cancer surgery

May 15, 2012, Henry Ford Health System

Women do better than men after surgical removal of part or all of a cancerous kidney, with fewer post-operative complications, including dying in the hospital, although they are more likely to receive blood transfusions related to their surgery.

But Henry Ford Hospital researchers who documented these can't say why they exist.

The results of the new study, based on population samples from throughout the U.S., will be presented this week at the American Urological Association's Annual Meeting in Atlanta.

"This is a controversial area," says Quoc-Dien Trinh, M.D., a Fellow at Henry Ford Hospital's Vattikuti Urology Institute and lead author of the study.

"While the effects of gender on the outcome of many types of surgery, including removal of the bladder, have been demonstrated and widely debated, the association between gender and of nephrectomy (kidney removal) is not well understood."

Physical differences between genders can explain different outcomes in some types of surgery, and have been shown and discussed in several earlier studies, Dr. Trinh says. "But this is hard to explain for nephrectomies. There is no clear-cut anatomical difference between men and women that would explain why it's easier or harder in one sex than the other."

Surgical removal of part or all of a diseased kidney, whether using traditional "open" techniques or less-intrusive , is the standard of care for kidney cancer and the only .

Using nephrectomy data from 1998 through 2007, the most recent available from the Health Care Utilization Project's Nationwide Inpatient Sample (NIS), "we tested the rates of blood transfusions, extended length of stay (beyond the median of five days), in-hospital mortality, as well as complications during and after surgery, separated by gender," Dr. Trinh says.

Of the total 48,172 cases that were identified and examined, 18,966 (39.4 percent) were female. The mean age for the women was 62.7 years; for the men, 61.8 years.

While no significant gender-related differences were found in complications during surgery and length of hospital stay after , the Henry Ford Hospital researchers found that women:

  • Were less likely than men (14.6 percent vs. 17.1 percent) to have complications after nephrectomy. These included digestive problems, hemorrhage, cardiac complications and infections.
  • Were less likely to die while in the hospital (0.6 percent vs. 0.8).
  • Were more likely to have blood transfusions than men (11.5 percent vs.9.2 percent).
The differences were most pronounced after partial removal of a cancerous kidney using open surgical techniques.

Because researchers didn't have specific data on the tumors in each individual case, exactly why these differences were found couldn't be determined, Dr. Trinh says, adding, "It is entirely possible that women have smaller tumors, so there are fewer complications."

As to the higher rates of blood transfusion in female patients, Dr. Trinh says the reason or reasons remain unknown.

"The threshold for transfusion could be different between men and women," he says. "We usually transfuse based on clinical decisions: we look at the patients, how they're doing, and make judgments. There are no clear-cut guidelines.

"In the end, are transfused more often. Is it because they bleed more often? Are they transfused more liberally than ? We don't have the data to answer this."

While these differences remain to be explored and determined, the fact that they exist, and have now been documented, is a step forward in the treatment of .

"Insight into the effect of gender on major urologic oncology procedures," Dr. Trinh says, "is critical in reducing disparities in care and improving patient outcomes."

Explore further: Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients

Related Stories

Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients

May 15, 2012
An increasingly common and safer type of surgery for kidney cancer is not as likely to be used for older, sicker and poorer patients who are uninsured or rely on Medicare or Medicaid for their health care, according to a ...

Prostate cancer surgery better at teaching hospitals

November 7, 2011
Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry ...

Fewer prostate cancer surgery complications found in teaching hospitals with fellowship programs

May 15, 2012
Patients who undergo radical surgery for prostate cancer may expect better results, on average, if they're treated in accredited teaching hospitals with residency programs, and better still if the hospitals also have medical ...

Fewer complications, better outcomes with robot-assisted prostate cancer surgery

April 24, 2012
Robot-assisted surgery is now both more common and far more successful than radical "open" surgery to treat prostate cancer in the United States, according to a new Henry Ford Hospital study published in the current issue ...

Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery

May 15, 2012
Older, sicker, high-risk patients who undergo one of the most common treatments for prostate cancer get better results in larger, busier hospitals, according to new research by Henry Ford Hospital.

Better short-Term outcomes for private prostatectomies

March 30, 2012
(HealthDay) -- For men undergoing radical prostatectomies (RPs), private health insurance coverage is linked with fewer complications, less in-hospital recovery time, and decreased mortality, compared to public coverage, ...

Recommended for you

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.